Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of ryokeijutsukanto for orthostatic dysregulation
jRCT1031200297Recruiting
- Sponsor
- Kazuhiro Hirasawa
- Start
- Jan 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of ryokeijutsukanto in orthostatic intolerance, sponsored by Kazuhiro Hirasawa. Primary endpoint: Vertigo Symptom Scale short form score. Started Jan 2021; status: recruiting.
02
Drugs
ryokeijutsukanto
03
Conditions
orthostatic intolerance
Beyond the preview
Go deeper on jRCT1031200297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031200297.